The nail under fungal siege in patients with type II diabetes mellitus

Mycoses

Volumn 48, Issue 5, 2005, Pages 339-342

  Piérard, Gérald E ^a,b   Piérard Franchimont, Claudine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Diabetic foot; Nail fungus; Onychomycosis

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOULD; NAIL DYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONYCHOMYCOSIS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; YEAST; COMPARATIVE STUDY; DIABETES MELLITUS; MICROBIOLOGY; MIDDLE AGED; NAIL DISEASE;

ARTHRODERMATACEAE; FUNGI;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; ONYCHOMYCOSIS; PROSPECTIVE STUDIES;

EID: 27744489368     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2005.01140.x     Document Type: Article

References (27)

1. Piérard GE. Onychomycosis and other superficial fungal infections of the foot in the elderly. A pan-European survey. Dermatology 2001; 202: 220-4.
2. Macura AB, Macura-Beigun A, Pawlik B. Susceptibility to fungal infections of nails in patients with primary antibody deficiency. Comp Immunol Microbiol Infect Dis 2003; 26: 223-32.
3. Greene RA, Scher RK. Nail changes associated with diabetes mellitus. J Am Acad Dermatol 1987; 16: 1015-21.
4. Evans SL, Nixon BP, Lee I, Lee D, Mooradian AD. The prevalence and nature of pediatric problems in elderly diabetic patients. J Am Geriatr Soc 1991; 39: 241-5.
5. Alteras I, Saryt E. Prevalence of pathogenic fungi in the toe-webs and toe-nails of diabetic patients. Mycopathologia 1979; 16: 157-9.
6. Lugo-Somolinos A, Sanchez JL. Prevalence of dermatophytosis in patients with diabetes. J Am Acad Dermatol 1992; 26: 408-10.
7. Levy LA. Epidemiology of onychomycosis in special risk populations. J Am Pediatr Med Assoc 1997; 87: 546-50.
8. Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol 1996; 35: S10-S2.
9. Gupta AK, Konnikov N, MacDonald P et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998; 139: 665-71.
10. Raboobee N, Aboobaker J, Peer AK. Tinea pedis et unguium in the Muslim community of Durban, South Africa. Int J Dermatol 1998; 37: 759-65.
11. Rich P, Hare A. Onychomycosis in special population. Focus on the diabetic. Int J Dermatol 1999; 38: S17-S9.
12. Rosseeuw D, Katsambas A, Burzykowski T et al. The risk of fungal foot infections in diabetic patients. J Eur Acad Dermatol Venereol 1999; 12: S220.
13. Gupta AK, Gupta MA, Summerbell RC et al. The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol 2000; 14: 466-9.
14. Gupta AK, Humke S. The prevalence and management of onychomycosis in diabetic patients. Eur J Dermatol 2000; 10: 379-84.
15. Romano C, Massai L, Asta F, Signorini AM. Prevalence of dermatophytic skin and nail infections in diabetic patients. Mycoses 2001; 44: 85-6.
16. Dogra S, Kumar S, Bhansali A, Chakrabarty A. Epidemiology of onychomycosis in patients with diabetes mellitus in India. Int J Dermatol 2002; 41: 647-51.
17. Piérard GE, Arrese JE, Pierre S et al. Diagnostic microscopique des onychomycoses. Ann Dermatol Venereol 1994; 121: 25-9.
18. Piérard GE, Arrese JE, De Doncker P, Piérard-Franchimont C. Present and potential diagnostic techniques in onychomycosis. J Am Acad Dermatol 1996; 34: 273-7.
19. Ginter G, Rieger E, Heigl K, Propst E. Increasing frequency of onychomycosis - is there a change in the spectrum of infectious agents? Mycoses 1996; 39(Suppl. I): 118-22.
20. Greer DL. Evolving role of nondermatophytes in onychomycosis. Int J Dermatol 1997; 34: 521-4.
21. Ghannoum MA, Hajjeh A, Scher R et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 2000; 43: 641-8.
22. Arrese JE, Pierard GE. Treatment failures and relapses in onychomycosis: a stubborn clinical problem. Dermatology 2003; 207: 255-60.
23. Piérard GE, Arrese JE, Quatresooz P. Histomycologie de la biodiversité des onychomycoses. In: Baran R, Piérard GE (eds), Onychomycoses. Paris, France: Publ. Abrégés Masson, 2004: 91-104.
24. Rurangirwa A, Piérard-Franchimont C, Piérard GE. Growth of Candida albicans on the stratum corneum of diabetic and non-diabetic patients. Mycoses 1990; 33: 253-5.
25. Gallo RL, Murakami M, Ohtake T, Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 2002; 110: 823-31.
26. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
27. Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL. Innate immune defense of the nail unit by antimicrobial peptides. J Am Acad Dermatol 2004; 50: 343-8.